Keywords: sucampo, licenses, tacrolimus, ophthalmic, uses, pharmaceuticals, formerly

Sucampo licenses tacrolimus for ophthalmic uses

Article | 25 February 2002

Sucampo Pharmaceuticals (formerly R-Tech Ueno USA) has signed anagreement with Fujisawa Pharmaceutical of Japan for an exclusive license to the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Fujisawa Pharmaceutical

Go to company listing

Related Drugs

Prograf

tacrolimus

Protopic

Go to drug listing